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A novel mathematical model to simulate stem cells differentiation into specialized
cells of connective or non-connective tissues is discussed. The model is based upon ma-
terial balances for extra cellular matrix compounds, growth factors and nutrients coupled
with a mass-structured population balance describing cell growth, proliferation and
differentiation. The model is written in a general form and it may be used to simulate a
generic cell differentiation pathway occurring in vivo or during in vitro cultivation when
specific growth factors are used. Several example are discussed where literature experi-
mental data are successfully compared with model results, thus demonstrating the valid-
ity of the proposed model as well as its predictive capability.
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Introduction
Stem cells are currently receiving a great atten-
tion since they represent a potential source of cells
for transplantation. In fact these cells have the abil-
ity to self-renew and differentiate into functional
cells of various tissues.1,2 Proliferative capacity of
many adult tissue-specific cells is very limited, so
that their expansion in vitro results to be difficult,
even during long-term cultivation which in addition
reduces their functional quality. Thus, attention is
currently devoted to the use of stem cells or progen-
itor ones instead of tissue-specific cells.3 Adult
stem cells may be obtained from tissues (liver, in-
testine, retina, skin, muscle, mammary glands and
others) of individual patients so that reimplantation
of in vitro cultivated cells/tissues would avoid prob-
lems of rejection. Despite this very attractive op-
portunity, the use of adult stem cells is limited by
the ability to identify these rare cells from the heter-
ogeneous tissue population and to expand them
in vitro.2 Mesenchymal stem cells (MSCs), also
known as marrow stromal cells, which are progeni-
tors of all tissue cells, can be on the other hand iso-
lated using standard techniques, expanded in cul-
ture, and stimulated to differentiate into the desired
tissues.4,5 MSCs may differentiate into specialized
cells to form bone, cartilage, tendon, dermal, adi-
pose and muscle tissues. In addition, MSCs may
differentiate into hepatic, renal, cardiac and neural
stem cells.6 These properties open up therapeutic
opportunities for the treatment of lesions in
mesenchymal tissues so that protocols have been
devised for the treatment of defects in articular car-
tilage, bone, tendon, meniscous and for bone mar-
row stromal recovery and osteogenesis imperfecta.5
When forming connective tissues, cells secrete
macromolecules (collagen and proteoglycans mainly
represented by glycosaminoglycan, GAG) which
constitute the extra-cellular matrix (ECM). The lat-
ter provides an organized environment wherein mi-
gratory cells can move and interact with one an-
other and stationary cells are anchored.3 Recent
studies suggested that the use of three-dimensional
scaffold may improve, quantitatively, the differenti-
ation of stem cells.7,8 These investigations are fo-
cused on the identification of the more suitable cul-
tivation scaffolds and the optimization of the me-
chanical and physical properties of such materials.
A very important role on cell differentiation is
played by growth factors (GFs), which are proteins
that bind to receptors on the cell surface, with the
primary result of activating cellular proliferation
and/or differentiation. Many growth factors are
quite versatile, stimulating cellular division in sev-
eral different cell types, while others are specific to
a particular cell-type. Among the various growth
factors, bone morphogenetic protein (BMP) which
belongs to the transforming growth factor-
(TGF-) superfamily, plays an important role in the
regulation of the differentiation pathway of MSCs.9
In particular, these growth factors may induce the
differentiation of MSCs into connective cells such
as osteoblasts, chondrocytes and adipocytes.9 Sev-
eral papers are focused on experimental studies
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concerning the mesenchymal stem cell differen-
tiation into chondrocytes stimulated by TGF-
superfamily.5,10–17 Further studies are required since
the effect of this type of growth factors are in some
cases contradictory and mechanisms concerning
cell proliferation/differentiation and the interaction
with growth factors need to be elucidated.
An important contribution along these lines
may be provided by predictive models which
should facilitate the experiments, thus helping to
find the optimal operating conditions and at the
same time contributing to the understanding of bio-
logical mechanisms and stem cell behavior. For this
reason several contributions on the modeling of
these systems are available starting with the sto-
chastic model of stem cell proliferation proposed by
Till et al.18 More recently, a remarkable attempt to
simulate cell differentiation for ex-vivo hemato-
poiesis in the presence of TGF-1 is done by.19
These authors developed a mathematical model
based on population balance (PB) which describes
the hematopoiesis starting from a colony of hemato-
poietic stem cell. The model uses a tank and tubular
reactor metaphor to describe the (pseudo)-stochas-
tic and deterministic elements of hematopoiesis.
Bailon-Plaza and van der Meulen20 proposed a
two-dimensional mathematical model for simulat-
ing the effect of growth factor on fracture healing.
The model describes the differentiation of
mesenchymal stem cells into chondrocytes and
osteoblasts during a fracture healing by accounting
for material balance of the involved cells
(mesenchyms, chondrocytes and osteoblasts) to-
gether with a material balance on ECMs and growth
factors. In addition, Hentschel et al.21 developed a
mathematical model which describes the dynamic
mechanisms for skeletal pattern formation in the
vertebrate limb when growth factors (fibroblast
growth factor, FGF, and TGF-s) are present. Be-
side the works considered above, other authors
have addressed the simulation of cell differentia-
tion. For the sake of brevity, a list of the most inter-
esting models available in the literature on this sub-
ject is summarized in table 1. The main limitation
of these models is represented by the absence of the
description of the cell size distribution and its influ-
ence on cellular metabolism and differentiation.
In this paper, we propose a novel mathematical
model to simulate stem cells differentiation into
specialized cells. The model, along the lines of our
previous contributions27–31 is based upon material
balances for extra cellular matrix compounds,
growth factors and nutrients as well as mass-struc-
tured population balance to simulate cell growth,
differentiation and proliferation in vivo or during in
vitro cultivation. The proposed model is written in a
general form and may be used to simulate a generic
cell differentiation pathway occurring during in vi-
tro cultivation of connective and non-connective
tissues. Literature experimental data concerning the
differentiation of mesenchymal stem cells into
chondrocytes in terms of total DNA and GAG con-
tent are successfully compared with model results,
thus demonstrating the validity of the proposed
model as well as its predictive capability. In addi-
tion, literature experimental data concerning the
differentiation of murine central nervous stem cells
into astrocytes are also successfully compared with
model results, thus further demonstrating the valid-
ity of the proposed model as well as its predictive
capability.
Mathematical modeling
The proposed mathematical model for stem
cell differentiation into connective or non-connec-
tive tissues is based on the pathway schematically
shown in Fig. 1. Stem cells may differentiate into
specialized cells of type 1 under the influence of
specific growth factors GF1. Stem cells may also
differentiate into specialized cells of type 2 by
means of a different class of growth factors GF2.
These cells may be also obtained by the differentia-
tion of specialized cells of type 1 under the influ-
ence of the specific growth factor GF2. All the cells
involved in the pathway shown in Fig. 1 undergo
mitosis and may synthesize two extra cellular
matrix compounds, i.e. ECM1 and ECM2. This
scheme may involve more cell types and different
pathways of cell specialization starting from a stem
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T a b l e 1 – Models concerning the simulation of cell differ-
entiation processes
Model Reference
Stochastic model of stem cell proliferation for
spleen colony-forming cells
[18]
Model of differentiation processes in the thymus [22]
Stochastic model of brain cell differentiation [23]
Pseudo-stochastic and deterministic model
for ex-vivo hematopoiesis
[19]
Stochastic model of proliferation and





Dynamic mechanisms for skeletal pattern
formation in the vertebrate limb in the presence
of growth factors
[21]
Dynamic model for cellular differentiation
and co-expression properties of switch networks
[25]
Mathematical model for the interaction
of transcription factors
[26]
cell population (i=1). It is apparent that the path-
way shown in Fig. 1 can be simplified when the
differentiation into non-connective tissues is taking
into account. In the latter case the presence of ECM
is non accounted for.
As it may be seen, the mathematical model is
able to simulate cell growth, proliferation and dif-
ferentiation into intermediate or specialized cells
during cell cultivation in the presence of culture
medium and specific growth factors. The model ac-
counts for the ECM compounds secreted by cells
and is aimed to quantitatively describe the effect of
growth factors during cell differentiation. The
model is written in a general form and may be used
for simulating the differentiation of stem cells into
intermediate and specialized cells of various type.
Thus, by properly modifying the network scheme,
growth kinetics and differentiation rate expressions,
this model may be used to simulate and describe
different pathologies involving cell growth and dif-
ferentiation (i.e. tumors development, infections,
arthritis, etc.) or to guide the investigation on in vi-
tro/in vivo cell cultivation, growth and differentia-
tion in tissue engineering.
Specifically, the proposed model is based on
the following mass structured population balance
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where symbol’s significance is reported in the nota-
tion. In equation (1) the first two terms of the
right-hand-side represent the birth (i.e. a mother
cell may be divided in two daughter cells) and the
death of the cell of i-th type due to mitosis. The
third term of the right-hand-side of equation (1) ac-
counts for the gain of the cell of i-th type due to dif-
ferentiation from cells of k-th type (with ki) as
stimulated by the j-th growth factor. Finally, the
fourth term is represented by the loss of the cell of
i-th type due to differentiation. It is worth mention-
ing that the cellular death by apoptosis is neglected
since it may be relevant only in the case of
apoptotic/necrotic tissues.
By considering the approach described in detail
in previous works [27–31] cell mitotic fraction, i
F ,
and the cell mass growth rate,  i , appearing in
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On the other hand, by taking into account its
dependence upon the specific growth factor con-
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F i g . 1 – Schematic representation of the cell differentiation
pathways. Stem cells may differentiate into specialized cells of
type 1 under the influence of specific growth factors GF1. Stem
cells may also differentiate into specialized cells of type 2 by
means of a different class of growth factors GF2. These cells
may be also obtained by the differentiation of specialized cells
of type 1 under the influence of the same growth factor GF2.
centration up to a maximum constant saturation
value20 the differentiation rate ij













By assuming negligible mass transfer, popula-
tion balance (1), along with initial (2) and boundary
conditions (3) and equations (4)-(8) are coupled
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for i = 1,…, NC (10)
where symbol’s significance is reported in the nota-
tion.
Extracellular matrix, quantitatively described
by equations (9)-(10), is secreted by the cell of
the i-th type, whose differentiation is promoted
by growth factor j. It should be noted that the reac-
tive terms of equations (9)-(10), which describe
ECM1 and ECM2 synthesis, respectively, are
written in form of a product-inhibited kinetics, as
discussed in previous works [27–31] and account
for the total cellular mass per unit volume (i.e.












). It should be also noted that in
equations (9)-(10) the degradation of ECM com-
pounds is not considered. The growth factor con-
centration as a function of time is simulated by the
present model either in the case of in vitro (eq. 11a)
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for j = 1,…, NGF (in vivo) (11b)
where symbols’ significance is reported in the nota-
tion.
Equation (11), which describes the growth fac-
tor consumption, accounts for a yield  ij which re-
lates, as discussed in what follows, the differentia-
tion rate of the generic i-th cell to the consumption
of the j-th growth factor. If cell differentiation oc-
curs in vivo (as in the case of the fracture healing
described by Bailon-Plaza and van der Meulen20 an
additional term should be introduced to account for
the local growth factor production which is as-
sumed to be proportional to the mass of cell of k-th
type, as it may be seen in equation (11b).
The following initial conditions for equations
(9)-(11), for which symbols’ significance is re-
ported in the notation, hold:
C CECM i ECM i1 1
0
, , ; C CECM i ECM i2 2
0
, , and
C CGF GFj j
0 at t  0 (12)
When considering the case of non-connective
tissues, the model described above consists of equa-
tions (1)-(8) and (11) while in equation (12) only
the initial condition related to growth factors is
taken into account.
The system of ordinary differential equations
(9)-(11) along with initial conditions (12) requires
the knowledge of the cell distribution function, i
of i-th type of cells, which is obtained from the so-
lution of the population balance expressed by equa-
tion (1). It represents a partial differential equation
in the variables t and m, which is solved by
discretizing the derivative whose independent vari-
able is the cell mass m. After the choice of the up-
per limit, the mass domain is divided using a con-
stant step size mesh, and only the partial derivative
with respect to m is discretized by backward finite
difference. Thus, the partial integro-differential
equation (1) is transformed into a system of ordi-
nary differential equations. The latter one, coupled
with equations (9)-(11) along with initial conditions
(12), represents a larger system of ordinary differ-
ential equations which is solved as an initial value
problem with the Gear method by taking advantage
of standard numerical libraries. 101 grid points (in-
cluding the first one which corresponds to m=0) in
the mass domain are typically used for numerically
solving the PB model, since finer grids did not pro-
vide significant improvements in accuracy.
Results and discussion
Let us consider as a first example to demon-
strate the validity of the proposed model approach,
the case of stem cell differentiation in specialized
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cells of connective tissues. The case study refers
to the differentiation of mesenchymal stem cells
(MSCs) into chondrocytes cells (CCs) stimulated
by a specific growth factor of TGF- family.
Mesenchymes and chondrocytes may secrete GAG
and collagen as extracellular matrix components.
For this application the general differentiation path-
way reported in Fig. 1 may be simplified as shown
in Fig. 2.
To test the capabilities of the proposed model
we take advantage of experimental data reported
by Barry et al.5 who investigated the in vitro
chondrogenic differentiation of human mesenchymal
stem cells from bone marrow by means of different
growth factors (i.e., TGF-1, TGF-2 and TGF-3).
They isolated and centrifuged MSCs to obtain one
culture pellet and cultivated for 21 days under cul-
ture medium in presence of TGF-1, or TGF-2 or
TGF-3. Experimental data were reported in terms
of DNA and GAG content for each experiment per-
formed. Firstly, model results are directly compared
with experimental data obtained when growth fac-
tor TGF-1 was used. It should be noted that the
cell content is here expressed as g of DNA where
the characteristic weight of 7.7 pg of DNA per cell
has been assumed (Wilson et al., 2002). Model pa-
rameters used in simulation run, whose values are
reported in table 2, were taken from the literature
related to either the original work from which the
experimental data have been generated or to spe-
cific sources where the corresponding values are
available. Fig. 3a and 3b show a good agreement
between model results and experimental data in
terms of DNA and GAG content as a function of
cultivation time. It is worth noting that the un-
known model parameters (i.e., kinetic constants for
GAG synthesis, kECM i1, appearing in equation (9)
and parameters a11, b11 and 11 of equation (3)) are
estimated by means of a nonlinear least-square pro-
cedure against the experimental data. The regres-
sion analysis gives rise to an average percentage er-
ror of 22.0. Analogously, model results were com-
pared with experimental data obtained when culti-
vation was carried out by using growth factor
TGF-2. Model parameters used in this simulation
run are reported in table 3.
Also in this case, as shown in Fig. 4a and 4b,
the agreement between model results and experi-
mental data is satisfactory and the regression analy-
sis provides an average percentage error of 10.2.
It should be noted that, since the experimental
data used so far are given in terms of DNA mass,
the population balance adopted in our model would
have been based on DNA mass as internal variable.
However, cell mass-structured population balances
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F i g . 2 – Schematic pathway for mesenchymal cells differ-
entiation into chondrocytes stimulated by TGF-
T a b l e 2 – Model parameters used in the simulation of
mesenchymal stem cells differentiation into chondrocyte cells
stimulated by TGF-1 (i=1 for MSCs, i=2 for CCs; j=1 for
TGF-1). Experimental data from Barry et al.5 The regression
analysis provides an average percentage error of 22.0.
Parameter Value Unit Reference
i
0 (i=1) 2.0 · 105 cells/pellet [5]
CGF j
0 (j=1) 10 · 10–3 ng/mm3 [5]
CECM i1
0
, (i=1) 3 dw% [5]
CECM i1
0
, (i=2) 0 dw% [5]
CECM i2
0
, (i=1,2) 0 dw% [5]
CECM i
L
1, (i=1,2) 11.7 dw% [32]
CECM i
L
2, (i=1,2) 50.4 dw% [32]
dci (i=1,2) 1.14 · 10
6 ng/mm3 [33]
dECM i1, (i=1,2) 1.85 · 10
6 ng/mm3 [34]
dECM i2, (i=1,2) 1.44 · 10
6 ng/mm3 [34]
dW 1.0 · 10
6 ng/mm3 [35]
CO 2 0.124 · 10
–6 mmol/mm3 [36]
Cm 0.006 · 10
–6 mmol/mm3 [36]
0,i (i=1,2) 0.4 ng [37]
i (i=1,2) 0.125 ng [38]
qi (i=1,2) 40 – [38]
C i, (i=1,2) 1.0 · 10
–3 1/h [39]
i (i=1,2) 2.646 ng/(mm
2 h) [29]
kECM i2, (i=1,2) 0.015 · 10
3 dw% mm6/(ng mmol h) [29]
kECM i1, (i=1,2) 1.23 · 10
3 dw% mm6/(ng mmol h) [30]
aij (i=1; j=1) 0.76 1/h [30]
bij (i=1; j=1) 1.01 · 10
–3 ng/mm3 [30]
ij (i=1; j=1) 5.80 · 10
–3 ng of GF/ng of cells [30]
of the type adopted in this work seem more appro-
priate when describing metabolic/mitotic/differenti-
ation processes which are directly related to cell
size and thus to the corresponding mass.
To test the predictive model capability, the ex-
perimental data performed with TGF-3 are then
simulated. This growth factor has a comparable
effect with respect to TGF-2 on mesenchymal
differentiation into chondrocytes.5 By using the
same parameters of table 3, i.e. without any fitting
procedure, model predictions and experimental
data by Barry et al.5 were compared in terms of
DNA and GAG content as a function of cultivation
time. The good agreement between model results
and experimental data shown in Figs 5a and 5b
demonstrates the predictive capability of the model.
A further example which clearly shows the
model capabilities is represented by the simulation
of the effect of the growth factor concentration in
the culture medium when considering experimental
data by Bai et al.12 These data refer to in vitro dif-
ferentiation of human mesenchymal stem cell from
bone marrow into chondrocyte cells. In this case
MSCs were isolated, centrifuged to obtain a culture
pellet and cultivated for 21 days under a culture
medium in presence of TGF-1 and/or CDMP-1
(cartilage-derived morphogenic protein-1). In par-
ticular, experimental data concerning GAG content
within the pellet after 21 days of cultivation as a
function of different concentration of growth factor
CDMP-1 (from 50 to 500 ng/ml) with a constant
quantity of TGF-1 (10 ng/ml) has been simu-
lated.30 Also in this case model parameters (re-
ported in table 4) used in the simulation are taken
from the literature related to either the original
work from which the experimental data have been
generated or to specific sources where the corre-
sponding values are available. It should be noted
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T a b l e 3 – Model parameters used in the simulation of
mesenchymal stem cells differentiation into chondrocyte cells
stimulated by TGF-2 or TGF-3 (i=1 for MSCs, i=2 for CCs;
j=1 for TGF-1 or TGF-3). Experimental data from Barry et
al.5 The regression analysis provides an average percentage
error of 10.2.
Parameter Value Unit Reference
i
0 (i=1) 2.0 · 105 cells/pellet [5]
CGF j
0 (j=1) 10 · 10–3 ng/mm3 [5]
CECM i1
0
, (i=1) 3 dw% [5]
CECM i1
0
, (i=2) 0 dw% [5]
CECM i2
0
, (i=1,2) 0 dw% [5]
CECM i
L
1, (i=1,2) 11.7 dw% [32]
CECM i
L
2, (i=1,2) 50.4 dw% [32]
dci (i=1,2) 1.14 · 10
6 ng/mm3 [33]
dECM i1, (i=1,2) 1.85 · 10
6 ng/mm3 [34]
dECM i2, (i=1,2) 1.44 · 10
6 ng/mm3 [34]
dW 1.0 · 10
6 ng/mm3 [35]
CO 2 0.124 · 10
–6 mmol/mm3 [36]
Cm 0.006 · 10
–6 mmol/mm3 [36]
0,i (i=1,2) 0.4 ng [37]
i (i=1,2) 0.125 ng [38]
qi (i=1,2) 40 – [38]
C i, (i=1,2) 1.0 · 10
–3 1/h [39]
i (i=1,2) 2.646 ng/(mm
2 h) [29]
kECM i2, (i=1,2) 0.015 · 10
3 dw% mm6/(ng mmol h) [29]
kECM i1, (i=1,2) 4.99 · 10
3 dw% mm6/(ng mmol h) [30]
aij (i=1; j=1) 0.73 1/h [30]
bij (i=1; j=1) 0.01 · 10
–3 ng/mm3 [30]
ij (i=1; j=1) 0.10 · 10
–3 ng of GF/ng of cells [30]
F i g . 3 – Comparison between model results and experimen-
tal data in terms of DNA (a) and GAG content (b) as a function
of culture time for experiments carried out with TGF-1
(Experimental data from Barry et al.5).
that the unknown model parameters (i.e., kinetic
constants for GAG synthesis, kECM 1 2, and parame-
ters a11, b11 and 11) were tuned to fit the GAG con-
tents after 21 days of cultivation when a concentra-
tion of CDMP-1 equal to 100 ng/ml was used.
Thus, by employing these parameters, the remain-
ing experimental data were predicted by the model
as shown in Fig. 6. The agreement between model
results and experimental data is satisfactory and
confirms the predictive capability of the proposed
model.
Finally, the reliability of the mathematical
modeling approach based on PB is tested by con-
sidering the differentiation of central nervous sys-
tem stem cells into astrocytes cells stimulated by a
specific growth factor.31 The differentiation path-
way reported in Fig. 1 may be simplified as shown
in Fig. 7.
The mathematical model for simulating stem
cell differentiation into specialized cells of
non-connective tissues is also simplified accord-
ingly, as discussed in the Modeling section. In this
example, mathematical model results are compared
with experimental data reported by Satoh et al.40
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F i g . 4 – Comparison between model results and experimen-
tal data in terms of DNA (a) and GAG content (b) as a function
of culture time for experiments carried out with TGF-2
(Experimental data from Barry et al.5).
F i g . 5 – Comparison between model predictions and exper-
imental data in terms of DNA (a) and GAG content (b) as a
function of culture time for experiments carried out with
TGF-3 (Experimental data from Barry et al.5).
F i g . 6 – Comparison between model predictions and exper-
imental data in terms of GAG content after 21 days of cultiva-
tion as a function of different concentration of CDMP-1
(Experimental data from Bai et al.12).
who investigated the LIF-induced differentiation
of multipotent neural stem cells of murine cen-
tral nervous system into astrocytes enhanced
by Activin A. Murine stem cells were seeded onto
poly-L-lysine, fibronectin, laminin-coated glass
coverslips and were cultivated with 10 ng/ml of
LIF. The effect of activin A on the stem cell differ-
entiation of MEB5 line into astrocytes was investi-
gated by adding 1 or 10 or 100 ng/ml of this growth
factor. Model parameters used in simulation run,
whose values are reported in table 5, are taken from
the literature related to either the original work
from which the experimental data have been gener-
ated or to specific sources where the corresponding
values are available. It should be noted that parame-
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T a b l e 4 – Model parameters used in the simulation of
mesenchymal stem cells differentiation into chondrocyte cells
stimulated by CDMP-1 (i=1 for MSCs, i=2 for CCs; j=1 for
CDMP-1). Experimental data from Bai et al.12 (0, 50, 100, 300,
500 ng/ml of CDMP-1 with addition of 10 ng/ml TGF-1).
Parameter Value Unit Reference
i
0 (i=1) 2.5 · 105 cells/pellet [5]
CECM i1
0
, (i=1,2) 0 dw% [5]
CECM i2
0
, (i=1,2) 0 dw% [5]
CECM i
L
1, (i=1,2) 11.7 dw% [32]
CECM i
L
2, (i=1,2) 50.4 dw% [32]
dci (i=1,2) 1.14 · 10
6 ng/mm3 [33]
dECM i1, (i=1,2) 1.85 · 10
6 ng/mm3 [34]
dECM i2, (i=1,2) 1.44 · 10
6 ng/mm3 [34]
dW 1.0 · 10
6 ng/mm3 [35]
CO 2 0.124 · 10
–6 mmol/mm3 [36]
Cm 0.006 · 10
–6 mmol/mm3 [36]
0,i (i=1,2) 0.4 ng [37]
i (i=1,2) 0.125 ng [38]
qi (i=1,2) 40 – [38]
C i, (i=1,2) 1.0 · 10
–3 1/h [39]
i (i=1,2) 2.646 ng/(mm
2 h) [29]
kECM i1, (i=1) 0.017 · 10
3 dw% mm6/(ng mmol h) [29]
kECM i2, (i=1,2) 0.015 · 10
3 dw% mm6/(ng mmol h) [29]
kECM i1, (i=2) 12.7 · 10
3 dw% mm6/(ng mmol h) [30]
aij (i=1; j=1) 0.30 · 10
–3 1/h [30]
bij (i=1; j=1) 0.07 · 10
–3 ng/mm3 [30]
ij (i=1; j=1) 0.68 · 10
–3 ng of GF/ng of cells [30]
F i g . 7 – Schematic pathway for central nervous system
stem cells differentiation into astrocytes stimu-
lated by LIF and Activine A
T a b l e 5 – Model parameters used in the simulation of the
differentiation of murine central nervous system stem cells into
astrocytes adding 10 ng/ml of LIF in the cultivation system.
i=1 for stem cells, i=2 for astrocytes; j=1 for LIF. Experimen-
tal data from Satoh et al.40
Parameter Value Unit Reference
ni
0 (i=1) 2.0 · 105 cells [40]
ni
0 (i=2) 0 cells [40]
CGF j
0 (j=1) 10 · 10–3 ng/mm3 [40]
dci (i=1,2) 1.14 · 10
6 ng/mm3 [33]
CO 2 0.124 · 10
–6 mmol/mm3 [36]
Cm 0.006 · 10
–6 mmol/mm3 [36]
0,i (i=1,2) 0.4 ng [37]
i (i=1,2) 0.125 ng [38]
qi (i=1,2) 40 – [38]
C i, (i=1,2) 1.0 · 10
–3 1/h [39]
i (i=1,2) 18.8 ng/(mm
2 h) [31]
ij (i=1; j=1) 3.80 · 10
–4 ng of GF/ng of cells [31]
aij (i=1; j=1) 1.05 · 10
–2 1/h [31]
bij (i=1; j=1) 0.07 · 10
–3 ng/mm3 [31]
ters q, 0,  and  are the same for each type of
cells since we do not have specific information for
murine stem cells and astrocytes. Figs 8a and 8b
show a good agreement between model results and
experimental data in terms of total cells and
astrocytes number, respectively, as a function of
cultivation time when 10 ng/ml of LIF are used
during the cell cultivation. It is worth noting that
the unknown model parameters (i.e., a11, 11 and  i)
are properly tuned to simulate the experimental
data.
Next, we compare model results with experi-
mental data obtained when cultivation was carried
out by using 10 ng/ml of LIF with an addition of
100 ng/ml of Activin A. Model parameters used in
this simulation run are reported in table 6. Also in
this case parameters qi, 0i, i and  i are the same
for each type of cells (i=1 and i=2). As shown in
Figs 9a and 9b, the agreement between model re-
sults and experimental data in terms of total cells
and astrocytes number as a function of cultivation
time, is satisfactory.
It should be noted that, in this simulation, the
only adjusted parameter is a12 (related to Activin A
growth factor), while no change has been made in
parameters a11, 11 (related to LIF) obtained from
the previous calculation. Furthermore, it is assumed
that b12 = b11 and 12 = 11. To test the predictive
model capability we then simulated the experi-
mental data performed when different dosages
of Activin A growth factor were used during the
cell cultivation. By using the same parameters
of table 6, i.e. without any fitting procedure,
we compare model predictions and experimental
data by Satoh et al.40 in terms of astrocytes per-
centage as a function of added Activin A in the
concentration range 0–100 ng/ml after 3 days of
cell cultivation. The good agreement between
model results and experimental data shown in
Fig. 10 demonstrates the predictive capability of the
model.
It is possible to observe that the augmentation
of Activin A increases the differentiation of stem
cells into astrocytes but this effect is not evident
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F i g . 8 – Comparison between model results and experimen-
tal data40 in terms of total cells (a) and astrocytes number (b)
as a function of cultivation time when 10 ng/ml of LIF are used
during cell cultivation
F i g . 9 – Comparison between model results and experimen-
tal data [40] in terms of total cells (a) and astrocytes number
(b) as a function of cultivation time when 10 ng/ml of LIF and
100 ng/ml of Activin A are used during cell cultivation
when the concentration of this growth factor is
equal or greater to about 20 ng/ml. This behavior
is well predicted by the model which therefore
could be an useful tool to optimize the growth fac-
tor dosage during cell cultivation and differentia-
tion.
Concluding remarks
In the present work the capability of a novel
mathematical model to simulate stem cells differen-
tiation into specialized cells is demonstrated. The
model, along the lines of our previous contributions
[27–31], is based upon material balances for extra
cellular matrix compounds, growth factors and nu-
trients as well as mass-structured population bal-
ance to simulate cell growth, differentiation and
proliferation in vivo or during in vitro cultivation.
The proposed model is written in a general form
and may be used to simulate a generic cell differen-
tiation pathway occurring during in vitro cultivation
of connective and non-connective tissues.
Literature experimental data concerning the
differentiation of stem cells into specialized ones
are successfully compared with model results, thus
demonstrating the validity of the proposed model,
as well as its predictive capability.
The proposed mathematical model may be eas-
ily extended by accounting for the presence of
drugs which may inhibit cell proliferation and/or
differentiation. This can be done by introducing
specific kinetic equations based upon typical en-
zyme-drug complex formation able to mimic the bi-
ologic behavior of proliferating cells in the pres-
ence of drugs. Therefore, this modeling approach
appears particularly useful in predicting evolution,
under pharmacologic treatment, of some iper-pro-
liferative diseases such as tumors and restenosis.
N o t a t i o n
a 	 parameter appearing in equation (8) and (11), 1/h
b 	 parameter appearing in equation (8) and (11),
ng/mm3
CECM1	 concentration of GAG, dw%
CECM2	 concentration of collagen, dw%
CGF 	 concentration of growth factor, ng/mm
3
CO2 	 concentration of O2 at saturation condition,
mmol/mm3
CL 	 maximum collagen or GAG concentration, dw%
Cm 	 oxygen concentration at half-maximal consump-
tion, mmol/mm3
d 	 mass density, ng/mm3
f(m) 	 division probability density function
kECM1	 rate constant for GAG synthesis, dw% mm
6/(ng
mmol h)
kECM2	 rate constant for collagen synthesis, dw%
mm6/(ng mmol h)
kGF
B 	 rate constant for in vivo GF synthesis, ng of
GF/(ng of cells h)
m 	 single cell mass, ng
NC 	 number of cell type
NGF 	 number of growth factors
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T a b l e 6 – Model parameters used in the simulation of the
differentiation of murine central nervous system stem cells into
astrocytes adding 10 ng/ml of LIF and 100 ng/ml of Activin A
in the cultivation system. i=1 for stem cells, i=2 for astrocytes;
j=1 for LIF, j=2 for Activin A. Experimental data from Satoh et
al.40
Parameter Value Unit Reference
ni
0 (i=1) 2.0 · 105 cells [40]
ni
0 (i=2) 0 cells [40]
CGF j
0 (j=1) 10 · 10–3 ng/mm3 [40]
CGF j
0 (j=2) 100 · 10–3 ng/mm3 [40]
dci (i=1,2) 1.14 · 10
6 ng/mm3 [33]
CO 2 0.124 · 10
–6 mmol/mm3 [36]
Cm 0.006 · 10
–6 mmol/mm3 [36]
0,i (i=1,2) 0.4 ng [37]
i (i=1,2) 0.125 ng [38]
qi (i=1,2) 40 - [38]
C i, (i=1,2) 1.0 · 10
–3 1/h [39]
i (i=1,2) 18.8 ng/(mm
2 h) [31]
ij (i=1; j=1; j=2) 3.80 · 10
–4 ng of GF/ng of cells [31]
aij (i=1; j=1) 1.05 · 10
–2 1/h [31]
aij (i=1; j=2) 0.39 · 10
–2 1/h [31]
bij (i=1; j=1; j=2) 0.07 · 10
–3 ng/mm3 [31]
F i g . 1 0 – Comparison between model prediction and ex-
perimental data [40] in terms of astrocytes content (%) as a
function of Activin A added during cell cultivation.
Nm 	 number of grid points for the mass domain
p 	 partitioning function
q 	 coefficient appearing in symmetric beta function
t 	 cultivation time, h
G r e e k l e t t e r s
(q,q)	 symmetric beta function
F 	 division rate function, 1/h
T 	 differentiation rate function, 1/h
0 	 average mass of dividing cells, ng
 	 maximum rate of cell growth, ng/(mm2 h)
c 	 catabolic rate, 1/h
 	 time rate of change of cell mass m, ng/h
 	 cell number per unit volume, cells/mm3
0 	 initial cell number per unit volume, cells/mm3 or
cells/pellets
 	 standard deviation of the Gaussian distribution, ng
 	 yield appearing in equation (11), ng of GF/ng of
cells
 	 cell distribution function, cells/(ng mm3)
S u p e r s c r i p t s
0 	 initial conditions
 	 mother cell
S u b s c r i p t s
c 	 cells
ECM1 	 component of ECM, glycosaminoglycan (GAG)
ECM2 	 component of ECM, collagen
GF 	 growth factor
i 	 i-th cell type
j 	 j-th growth factor
k 	 k-th cell type
O2 	 oxygen
w 	 water
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